CD8+CD28− T cells have been shown to suppress experimental inflammatory bowel disease in mice, and repeated stimulation of human peripheral blood lymphocytes with allogeneic APCs in vitro causes a loss of lymphocyte proliferative activity, owing to the actions of CD8+CD28− regulatory T cells39. This evidence concerns the gene CD28 and inflammatory bowel disease.